Orphan Drug for Pancreatic Cancer Tops SPT Week in Review

Orphan Drug for Pancreatic Cancer Tops SPT Week in Review

5. How Blockchain Technology Will Impact Specialty Pharmacy The benefits of adopting blockchain technology have not been overlooked by the health care industry and can have a direct and lasting impact on specialty pharmacy. Read more.   4. FDA OKs Treatment for HER2-Negative Breast Cancer with Germline BRCA Mutation   Talazoparib is indicated for […]

Protein mTOR regulated by Src in cancer growth

Protein mTOR regulated by Src in cancer growth

Researchers at Baylor College of Medicine and Texas Children’s Hospital have identified a connection between cancer proteins mTORC1 and Src… Researchers at Baylor College of Medicine and Texas Children’s Hospital have revealed a connection between mTORC1 and Src, two proteins known to be hyperactive in cancer. The study shows that Src is necessary and sufficient to […]

Merrimack Pharma's stock plunges (again) on its latest cancer drug trial flop

Merrimack Pharma's stock plunges (again) on its latest cancer drug trial flop

Richard Peters Merrimack Pharmaceuticals $MACK has another loser on its hands. The drug MM-121 (seribantumab) added to docetaxel did not do any better than docetaxel alone in improving the progression-free survival of patients suffering from non-small cell lung cancer. Merrimack’s stock, already blighted by trial failure, quickly plunged anew, dropping more than 30% on the […]

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push

Xconomy San Diego —  Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday. TP Therapeutics is developing a drug called […]

150-Year-old Drug May Improve Radiation Therapy for Cancer: Study

150-Year-old Drug May Improve Radiation Therapy for Cancer: Study

“}var y=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;$(“#main_score_strip_top”).html(y),set_score_slider_style()}else $(“#top_strip_cricket_widget”).html(“https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”),”undefined”!=typeof updateTopScoreWidgetNews18&&clearInterval(updateTopScoreWidgetNews18),console.log(“no live match in progress”)},error:function(e){console.log(“error in live score widget”),$(“#top_strip_cricket_widget”).html(“https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”)}})} function get_live_team_scores(e,s,i){var e=get_ipl_teams_short(e),t=s,i=i,a=”https://images.news18.com/static_news18/ibnlive/pix/ibnhome/cricketnext/microsite/teamsicon/”,r=a+e.toLowerCase()+”.png”,n=’‘,c=t.length;if(c>0){for(var o=1,v=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”,l=0;c>l;l++){var m=t[l].scores,p=t[l].wickets,f=t[l].overs,g=t[l].active;if(1==g)var d=”“,_=”“;else d=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”,_=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;if(2==o)var b=” & “;else var b=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;”test”==i?(v=v+”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”+b+d+m+”/”+p+_,o+=1):(v=v+”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”+d+m+”/”+p+”(“+f+”)”+_+b,o+=1)}var h=d+e+_;h=’ ‘+n+h+v+” “}else h=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;return h} function convertToSlug(e){return e.replace(” (W)”,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).replace(” (C)”,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).toLowerCase().replace(/[^w ]+/g,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).replace(/ +/g,”-“)} function get_ipl_teams_short(a){var r=new Array;return r.Kolkata=”KKR”,r.KOL=”KKR”,r.MUM=”MI”,r.Mumbai=”MI”,r.HYD=”SRH”,r.Hyderabad=”SRH”,r.PUN=”RPS”,r.Punjab=”KXIP”,r.PNJ=”KXIP”,r.Bangalore=”RCB”,r.BLR=”RCB”,r.Delhi=”DD”,r.DEL=”DD”,r.Pune=”RPS”,r.Gujarat=”GL”,r.GUJ=”GL”,r.TBC=”TBC”,a in r?r[a]:a} var updateTopScoreWidgetNews18=setInterval(function(){news18_top_widget_live_scores() }, 20000);}); Researchers from Ohio State University (OSU) in the […]

Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate cancer

Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate cancer

Swiss drugmaker Novartis made a big investment in radiopharmaceuticals with the Thursday announcement that it will acquire a US firm with an oncology drug in late-stage development. The company said it would acquire Endocyte, headquartered in West Lafayette, Indiana, for $2.1 billion, or $24 per share. The company has a radioligand therapy, Lu-PSMA-617, in Phase […]

Dawn Picken: A miracle cancer drug has given a friend new life

Dawn Picken: A miracle cancer drug has given a friend new life

Joanne Rye-McGregor is back from the dead. My friend greets me with a hug at Back Porch Cafe in central Mount Maunganui. As she walks, long grey curls brush her shoulders. Jo is 56 years old. She’s sinew and bone, her once medium frame lighter by about 20 kilograms. Cancer does that. When I saw […]